Health Care·Biotechnology·$351.5B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $3.31 | N/A | +0.76% |
management commentary, guidance changes, and full analysis available with Pro.
| +0.76% |
Tone: Cautiously Optimistic
Management expressed satisfaction with the EPS results, highlighting their commitment to shareholder value. However, they did not provide specific guidance for future quarters.
We are pleased with our EPS performance this quarter.
Our focus remains on delivering value to our shareholders.
AbbVie's earnings report shows a positive surprise in EPS, which contributed to a 1.18% increase in stock price. Investors may view this as a sign of resilience in the company's financial performance, even without revenue figures or future guidance. The management's cautious optimism suggests they are focused on maintaining stability and delivering shareholder value.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
OTIS WORLDWIDE CORP
Jan 31, 2022